MADISON, N.J., Jan. 4, 2016 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 34th Annual J.P. Morgan Healthcare Conference in San Francisco. Steve Rusckowski, the company's President and CEO, will discuss the company's vision, goals and five point strategy. The presentation is scheduled for Tuesday, January 12, 2016 at 7:30 p.m. Eastern Time.
The presentation will be webcast live during the conference and will be available to registered investors on the following site:
http://jpmorgan.metameetings.com/confbook/healthcare16/directlink?p=19703 http:///and to the public on www.QuestDiagnostics.com. In addition, the archived webcast will be available within 24 hours after the conclusion of the live event and will remain available until February 12, 2016.
About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 45,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com.
Dan Haemmerle (Investors): 973-520-2900
Dennis Moynihan (Media): 973-520-2800
SOURCE Quest Diagnostics